Ursodeoxycholic acid for primary biliary cirrhosis: Final results of a 12-year, prospective, randomized, controlled trial

American Journal of Gastroenterology

Volumn 97, Issue 8, 2002, Pages 2063-2070

  Papatheodoridis, George V ^a   Hadziyannis, Emilia S ^a   Deutsch, Melanie ^a   Hadziyannis, Stephanos J ^a,b  

^a HIPPOKRATION HOSPITAL   (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; URSODEOXYCHOLIC ACID;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LIVER FUNCTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 0036677471     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04280-6     Document Type: Article

References (34)

1. Immunological and histological studies in primary biliary cirrhosis
2. Primary biliary cirrhosis
3. Primary biliary cirrhosis
4. Management of primary biliary cirrhosis
5. Ursodeoxycholic acid for primary biliary cirrhosis: Lessons from the past - Issues for the future
6. Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications
7. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse
8. Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled doubleblind trial
9. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
10. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
11. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: Results of a double-blind controlled multicentric trial
12. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
13. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis
14. Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) - A Cochrane hepato-biliary systemic review
15. Ursodeoxycholic acid for primary biliary cirrhosis
16. Long-term treatment of primary biliary cirrhosis with ursodeoxycholic acid. The third year of a controlled trial
17. Transection of the oesophagus for bleeding oesophageal varices
18. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
19. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis
20. A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis
21. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
22. A placebocontrolled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid
23. Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis: A Swedish multicentre, double-blind, randomised controlled study
24. Ursodiol for the long-term treatment of primary biliary cirrhosis
25. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis
26. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
27. Extended follow-up of patients in the US multicenter trial of ursodeoxycholic acid in primary biliary cirrhosis
28. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients
29. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis
30. Prognosis in primary biliary cirrhosis: Model for decision making
31. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis
32. Serum bilirubin: A prognostic factor in primary biliary cirrhosis
33. Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis
34. URSO - Panacea or placebo?